AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062
AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development and commercialization for the latter’s DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC), which is being developed for the treatment of multiple tumor types. Daiichi Sankyo is developing the antibody drug conjugate for multiple tumors […]
COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response
July 20, 2020 No Comment
COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine (AZD1222) to be well tolerated besides generating strong responses in all evaluated participants against the COVID-19 causing SARS-CoV-2 virus. The early-stage COVID-19 vaccine trial is being led by Oxford University, […]
Continue reading …Farxiga : AstraZeneca gets FDA fast track status for heart failure after MI
July 20, 2020 No Comment
AstraZeneca has secured fast track designation for Farxiga (dapagliflozin) in the US for its use in reducing the risk of hospitalization for heart failure (hHF) or cardiovascular (CV) death in adults after an acute myocardial infarction (MI) or heart attack. The fast track designation for the oral once-daily sodium-glucose co-transporter-2 (SGLT2) inhibitor is based on […]
Continue reading …
Russian pharma company R-Pharm has reportedly signed an agreement with AstraZeneca for manufacturing the ChAdOx1 nCoV-19 vaccine being developed by the latter in collaboration with UK-based Oxford University. The entire world is pinning hopes on the ChAdOx1 nCoV-19 vaccine candidate, which reportedly seems to be the most probable to become the first vaccine against the […]
Continue reading …
Ascentage Pharma has entered into a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca to assess the combination of Bcl-2 and Bruton’s Tyrosine Kinase (BTK) inhibitors in a type of lymphoma. As per the collaboration terms, Ascentage Pharma will sponsor a clinical trial to evaluate the efficacy and […]
Continue reading …
US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility in Anagni, Italy, and prepare for large-scale commercial supply of AZD1222, the adenovirus vector based COVID-19 vaccine candidate of the University of Oxford. Catalent said that the agreement fast tracks […]
Continue reading …
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners in a deal worth up to $2.1 billion, in a move to expand its presence in cardiovascular disease. Corvidia Therapeutics, which is based in Boston, Massachusetts, was spun out from […]
Continue reading …CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
February 9, 2020 No Comment
CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the removal of anti-platelet agent ticagrelor during surgery requiring cardiopulmonary bypass (CPB). The CytoSorb whole blood adsorber has also been given CE Mark label expansion for the indication. It was earlier approved in the European Union for the […]
Continue reading …
AstraZeneca has signed a deal valued at about $390 million with Atnahs Pharma, a portfolio company of Triton Fund V, to sell five of its hypertension drugs to the latter as they have lost patent protection across the world. The deal will give Atnahs Pharma the global commercial rights to the hypertension medicines – Inderal (propranolol), […]
Continue reading …
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma acquisition news. Financial details of the two deals have not been disclosed. The divestments are being taken up in an effort to wrap up the $63 billion AbbVie acquisition of […]
Continue reading …
Business News Today
- Charger Solar project : 400MW solar power plant to be built in Refugio County, TX
- Shetland transmission project : SSEN Transmission finalizes main contracts
- Worldwide Facilities acquires surplus lines MGA Clearwater Underwriters
- Maya Capital Partners acquires Sparta Drive-Up Storage in Sparta, NJ
- Dakota Mountain Lodge acquires Waldorf Astoria Park City in Park City, Utah
- COVID-19 vaccine trials : Research Centers of America begins enrollment of healthy volunteers
- Dugong oil discovery has 40-120mboe estimated reserves, says Neptune Energy
- Chesapeake Utilities completes acquisition natural gas supplier Elkton Gas
- Turnspire to acquire STEMCO Air Springs business of EnPro Industries
- US-based EC Design acquires Australian stationery retailer kikki.K
